Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6)

Y. Miao, Daniela Dobre, Hiddo J. Lambers Heerspink, Michael B Brenner, M. E. Cooper, Hans Henrik Parving, Shahnaz Shahinfar, D E Grobbee, Dick de Zeeuw

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Pages (from-to)2209
Number of pages1
Issue number8
Publication statusPublished - Aug 2011
Externally publishedYes

Cite this